pt. 1. Respiratroy cancer -- Chemotherapy resistance in small cell lung cancer: consequences for the clinician and future prospects -- Multidrug resistance in small cell lung cancer -- Correlations between clinical outcomes and in vitro chemosensitivity testing in non-small cell lung cancer -- Liposomal formulations of chemotherapeutic drugs -- pt. 2. Breast cancer -- Tamoxifen resistance and breast cancer -- Resistance to endocrine therapy in breast cancer -- Heat shock proteins and drug resistance in breast cancer -- pt. 3. Other epithelial cancers -- Overcoming drug resistance in ovarian cancer -- Protein kinase C activation and the intrinsic drug resistance of human colon cancer -- pt. 4. Hematological malignancies -- Clinical relevance of p-glycoprotein-related multidrug resistance in hematological malignancies -- Prediction of cytotoxic drug resistance in acute leukemia -- pt. 5. Mechanisms of drug resistance -- Determinants of estramustine resistance -- Strategies for overcoming anthracycline resistance -- Cellular mechanisms of cisplatin resistance -- Radiation response in chemotherapy-resistant tumors -- Preclinical in vivo models of drug resistance.